Halozyme Therapeutics (NASDAQ:HALO) Stock Rating Reaffirmed by Benchmark themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Campbell Newman Asset Management Inc Reduces Holdings in Halozyme Therapeutics, Inc (NASDAQ:HALO) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) – Research analysts at Leerink Partnrs cut their Q1 2024 earnings estimates for shares of Halozyme Therapeutics in a note issued to investors on Wednesday, April 3rd. Leerink Partnrs analyst D. Risinger now anticipates that the biopharmaceutical company will post earnings of $0.58 per share for the quarter, […]
Halozyme Therapeutics, Inc (NASDAQ:HALO) Given Consensus Recommendation of Moderate Buy by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Halozyme Therapeutics, Inc (NASDAQ:HALO) Receives Average Rating of Moderate Buy from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.